Zepteon, Inc. is a privately held corporation founded in 2012 that has developed first in class chromatography resins capable of separating antibodies with specific sugar structures (nonfucosylated) that are more potent against diseases like cancer. This technology enables more effective therapeutics and can reduce cost and dosing requirements.

Biotechnology

Zepteon

Zepteon's headquarters in Boston, MA, United States

Austin W. Boesch

Maria Grunwald

Glen R. Bolton

Ronald Sia

Marc Silver

Tom Ransohoff

This department provides expert guidance and strategic counsel to enhance decision-making and problem-solving.

Advisory Services

Zepteon's Leadership Team includes Glen R. Bolton and 1 others.

Zepteon

Org chart

Board & advisors

Teams

Advisory Services

Leadership Team

Offices

Zepteon

Org chart

Board & advisors

Teams

Advisory Services

Leadership Team

Offices

Related companies